Advertisement
Advertisement
BNTX
BioNTech SE - ADR
87.74
USDSponsored
-1.39
-1.56%
Oct 30, 14:22 UTC -4
Open
BioNTech SE - ADR (BNTX) Earnings
BNTX Earnings Reports
Positive Surprise Ratio
BNTX beat 18 of 28 last estimates.
64%
Next Report
Next Week
Date of Next Report
Nov 03, 2026
Estimate for Q3 26 (Revenue/ EPS)
$1.08B
/$0.81
Implied change from Q2 26 (Revenue/ EPS)
+918.64%
/-125.00%
Implied change from Q3 25 (Revenue/ EPS)
-29.18%
/-775.00%
BioNTech SE - ADR earnings per share and revenue
On Aug 04, 2026, BNTX reported earnings of -3.24 USD per share (EPS) for Q2 26, missing the estimate of -2.13 USD, resulting in a -51.91% surprise. Revenue reached 105.60 million, compared to an expected 160.90 million, with a -34.37% difference. The market reacted with a -0.98% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 7 analysts forecast an EPS of 0.81 USD, with revenue projected to reach 1.08 billion USD, implying an decrease of -125.00% EPS, and increase of 918.64% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Bristol-Myers Squibb Co.
Report Date
Oct 29, 2026 For Q3 26
Estimate
$1.20
Actual
$1.35
Surprise
+11.66%
Regeneron Pharmaceuticals Inc
Report Date
Oct 30, 2026 For Q3 26
Estimate
$16.47
Actual
$20.07
Surprise
+21.79%
Illumina Inc
Report Date
Oct 29, 2026 For Q3 26
Estimate
$1.38
Actual
$1.44
Surprise
+4.18%
Insmed, Inc.
Report Date
Oct 29, 2026 For Q3 26
Estimate
-$0.38
Actual
-$0.46
Surprise
-19.82%
Incyte Genomics Inc
Report Date
Oct 29, 2026 For Q3 26
Estimate
-$3.92
Actual
-$3.60
Surprise
+8.33%
Alnylam Pharmaceuticals, Inc.
Report Date
Oct 29, 2026 For Q3 26
Estimate
$1.65
Actual
$16.26
Surprise
+885.34%
Exelixis Inc
Report Date
Oct 29, 2026 For Q3 26
Estimate
$0.81
Actual
$0.94
Surprise
+15.64%
Kymera Therapeutics, Inc. Common Stock
Report Date
Oct 29, 2026 For Q3 26
Estimate
-$1.29
Actual
-$1.32
Surprise
-2.17%
PTC Therapeutics, Inc.
Report Date
Oct 29, 2026 For Q3 26
Estimate
$0.34
Actual
$0.61
Surprise
+75.59%
Fortrea Holdings Inc. Common Stock
Report Date
Oct 29, 2026 For Q3 26
Estimate
$0.22
Actual
$0.28
Surprise
+26.53%
FAQ
What were BioNTech SE - ADR's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, BioNTech SE - ADR reported EPS of -$3.24, missing estimates by -51.91%, and revenue of $105.60M, -34.37% below expectations.
How did the market react to BioNTech SE - ADR's Q2 2026 earnings?
The stock price moved down -0.98%, changed from $92.25 before the earnings release to $91.35 the day after.
When is BioNTech SE - ADR expected to report next?
The next earning report is scheduled for Nov 03, 2026.
What are the forecasts for BioNTech SE - ADR's next earnings report?
Based on 7
analysts, BioNTech SE - ADR is expected to report EPS of $0.81 and revenue of $1.08B for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.